Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the interplay between MMP-2, CA II and VEGFR-2 via new sulfonamide-tethered isomeric triazole hybrids; Microwave-assisted synthesis, computational studies and evaluation
Mohamed Reda Aouad, Meshal A. Almehmadi, Fawzia Faleh Albelwi, et al.
Bioorganic Chemistry (2022) Vol. 124, pp. 105816-105816
Closed Access | Times Cited: 25

Showing 25 citing articles:

Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013–2023)
Shriefa Almutairi, Hanin Moh’d Kalloush, Nour A. Manoon, et al.
Molecules (2023) Vol. 28, Iss. 14, pp. 5567-5567
Open Access | Times Cited: 39
1,2,3-Triazole-Benzofused Molecular Conjugates as Potential Antiviral Agents against SARS-CoV-2 Virus Variants
Jehan Y. Al‐Humaidi, Marwa M. Shaaban, Nadjet Rezki, et al.
Life (2022) Vol. 12, Iss. 9, pp. 1341-1341
Open Access | Times Cited: 36
Phenylpyrazolone-1,2,3-triazole Hybrids as Potent Antiviral Agents with Promising SARS-CoV-2 Main Protease Inhibition Potential
Arafa Musa, Hamada S. Abulkhair, Ateyatallah Aljuhani, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 463-463
Open Access | Times Cited: 33
Discovery of novel tris-1,2,3-triazole-based hybrids as VEGFR2 inhibitors with potent anti-proliferative and cytotoxicity through apoptosis induction
Mosa Alsehli, Adeeb Al Sheikh Ali, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2025) Vol. 155, pp. 108131-108131
Closed Access
Recent advances in microwave-assisted synthesis of triazoles and their derivatives: a green approach toward sustainable development methods
Suman Swami, Neelam Sharma, Garvit Sharma, et al.
RSC Advances (2025) Vol. 15, Iss. 4, pp. 2361-2415
Open Access
New N -(1,3,4-thiadiazole-2-yl)acetamide derivatives as human carbonic anhydrase I and II and acetylcholinesterase inhibitors
Sam Dawbaa, Cüneyt Türkeş, Demokrat Nuha, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-19
Closed Access | Times Cited: 4
Exploring of N-phthalimide-linked 1,2,3-triazole analogues with promising ­anti-SARS-CoV-2 activity: synthesis, biological screening, and molecular modelling studies
Ateyatallah Aljuhani, Mosa Alsehli, Mohamed A. Seleem, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 3
The first-in-class pyrazole-based dual InhA-VEGFR inhibitors towards integrated antitubercular host-directed therapy
Marwa M. Shaaban, Mohamed Teleb, Hanan M. Ragab, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107179-107179
Closed Access | Times Cited: 2
Synthesis of Acyl Hydrazides and Hydrazones from Activated Amides
Sunwoo Lee, Miso Kim
Synthesis (2024) Vol. 56, Iss. 14, pp. 2263-2269
Closed Access | Times Cited: 2
Stereochemistry matters: Inhibition of carbonic anhydrase II by amino acid derived sulfamates depends on their absolute configuration
Toni C. Denner, Elsa L. Klett, Niels V. Heise, et al.
European Journal of Medicinal Chemistry Reports (2024) Vol. 11, pp. 100162-100162
Open Access | Times Cited: 2
Mechanistic study of the stabilization of dentin-bonded restorative interfaces via collagen reinforcement by multi-acrylamides
PMC Scaffa, MG Logan, MY Icimoto, et al.
Dental Materials (2024) Vol. 40, Iss. 8, pp. 1128-1137
Closed Access | Times Cited: 2
New sulfonamide-based glycosides incorporated 1,2,3-triazole as cytotoxic agents through VEGFR-2 and carbonic anhydrase inhibitory activity
Hebat‐Allah S. Abbas, Eman S. Nossier, May A. El‐Manawaty, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Syntheses, crystal structure, luminescent properties and Hirshfeld surface of a set of triazole-based salts
Bing-Qian Jin, Yu-Qing Song, Yin−Xue Ma, et al.
Journal of Molecular Structure (2023) Vol. 1279, pp. 134980-134980
Closed Access | Times Cited: 6
Battling colorectal cancer via s-triazine-based MMP-10/13 inhibitors armed with electrophilic warheads for concomitant ferroptosis induction; the first-in-class dual-acting agents
Christine A. Morcos, Sherine N. Khattab, Nesreen S. Haiba, et al.
Bioorganic Chemistry (2023) Vol. 141, pp. 106839-106839
Closed Access | Times Cited: 5
Non-small cell lung cancer sensitisation to platinum chemotherapy via new thiazole-triazole hybrids acting as dual T-type CCB/MMP-9 inhibitors
Hassan El Gamal, Khadiga Ahmed Ismail, A-Mohsen M. E. Omar, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 1
Nanoformulation-Based 1,2,3-Triazole Sulfonamides for Anti-Toxoplasma In Vitro Study
Fadwa M. Arafa, Heba Said, Doaa Hassan Osman, et al.
Tropical Medicine and Infectious Disease (2023) Vol. 8, Iss. 8, pp. 401-401
Open Access | Times Cited: 4
Revealing the contributions of DFT to the spectral interpretation for an amino benzoyl thiourea derivative: Insights into experimental studies from theoretical perspectives, and biological evaluation
Ahmed M. Hegazy, Nesreen S. Haiba, Mohamed K. Awad, et al.
New Journal of Chemistry (2023) Vol. 47, Iss. 35, pp. 16470-16483
Closed Access | Times Cited: 2
Identification of novel sulfathiazole‐triazolo‐chalcone hybrids as VEGFR‐2/EGFR dual inhibitors with antiangiogenic activity and apoptotic induction
Mohamed A. Zeidan, Dina I. A. Othman, Fatma E. Goda, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 3
Closed Access | Times Cited: 2
Design of Sulfonamide-Based Glycosides Incorporated with 1,2,3-Triazole Scaffold as Potential VEGFR-2 and Carbonic Anhydrase Inhibitors: Synthesis, Cytotoxic Activity and In Silico Studies
Mohamed N. El-Bayaa, Eman S. Nossier, May A. El‐Manawaty, et al.
Research Square (Research Square) (2024)
Open Access
A Review of Recent Progress on the Anticancer Activity of Heterocyclic Compounds
Beena Negi, Aarshiya Kwatra
SynOpen (2024) Vol. 08, Iss. 03, pp. 185-210
Open Access
Structure optimization and molecular dynamics studies of new tumor-selective s -triazines targeting DNA and MMP-10/13 for halting colorectal and secondary liver cancers
Christine A. Morcos, Nesreen S. Haiba, Rafik W. Bassily, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access
Discovery of Novel Tris-1,2,3-Triazole-Based Hybrids as Vegfr2 Inhibitors with Potent Anti-Proliferative and Cytotoxicity Through Apoptosis Induction
Mosa Alsehli, Adeeb Al Sheikh Ali, Mohamed S. Nafie, et al.
(2024)
Closed Access
Highly efficient construction of multi-substituted aminopyrazoles derivatives via iodine-mediated three-components reaction as potential anticancer agents
Zilin Gao, Wenbo Huang, Manli Liu, et al.
Green Chemistry Letters and Reviews (2023) Vol. 16, Iss. 1
Open Access
Promising anti-Toxoplasma activity of 1,2,3-triazole tethering sulfonamide moiety; synthesis; characterization and in vitro study
Fadwa M. Arafa, Doaa Hassan Osman, Mona Mohamed Tolba, et al.
Research Square (Research Square) (2022)
Open Access
Promising anti-Toxoplasma activity of 1,2,3-triazole tethering sulfonamide moiety; synthesis; characterization and in vitro study
Fadwa M. Arafa, Doaa Hassan Osman, Mona Mohamed Tolba, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top